[Contrast-enhanced mammography].
Kontrastmittelunterstützte Mammographie.
Breast cancer
Contrast-enhanced spectral mammography
Early diagnosis
Magnetic resonance imaging
Quality control
Journal
Der Radiologe
ISSN: 1432-2102
Titre abrégé: Radiologe
Pays: Germany
ID NLM: 0401257
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
accepted:
04
01
2021
pubmed:
19
1
2021
medline:
9
3
2021
entrez:
18
1
2021
Statut:
ppublish
Résumé
Early detection is of great importance for the successful treatment of breast cancer and for a good prognosis. Contrast-enhanced mammography and especially contrast-enhanced spectral mammography (CESM) show promising initial results and are a valuable addition to currently available methods. The advantage of these methods is that imaging of both breasts can be performed in a single examination with a single contrast agent application. The accuracy of CESM is similar to that of magnetic resonance imaging (MRI), easily available at low costs, which is why this procedure is increasingly used in the diagnostic work up of breast cancer. CESM is also a good alternative to MRI if this cannot be performed due to contraindications. Eine frühzeitige Erkennung ist für die erfolgreiche Behandlung des Mammakarzinoms sowie für eine gute Prognose von großer Bedeutung. Die Kontrastmittelmammographie und insbesondere die kontrastmittelverstärkte spektrale Mammographie (CESM) zeigt vielversprechende erste Ergebnisse und stellt eine wertvolle Ergänzung zu den derzeit verfügbaren Methoden dar. Der Vorteil dieses Verfahrens besteht darin, dass eine Bildgebung beider Brüste in nur einem Untersuchungsgang mit einer Kontrastmittelgabe erfolgen kann. Die CESM zeigt ähnlich gute Resultate wie die Magnetresonanztomographie (MRT), ist gut verfügbar und kostengünstig und findet daher zunehmend Anwendung in der Mammadiagnostik. Die CESM stellt auch eine gute Alternative zur MRT dar, wenn diese aufgrund von Kontraindikationen nicht durchgeführt werden kann.
Autres résumés
Type: Publisher
(ger)
Eine frühzeitige Erkennung ist für die erfolgreiche Behandlung des Mammakarzinoms sowie für eine gute Prognose von großer Bedeutung. Die Kontrastmittelmammographie und insbesondere die kontrastmittelverstärkte spektrale Mammographie (CESM) zeigt vielversprechende erste Ergebnisse und stellt eine wertvolle Ergänzung zu den derzeit verfügbaren Methoden dar. Der Vorteil dieses Verfahrens besteht darin, dass eine Bildgebung beider Brüste in nur einem Untersuchungsgang mit einer Kontrastmittelgabe erfolgen kann. Die CESM zeigt ähnlich gute Resultate wie die Magnetresonanztomographie (MRT), ist gut verfügbar und kostengünstig und findet daher zunehmend Anwendung in der Mammadiagnostik. Die CESM stellt auch eine gute Alternative zur MRT dar, wenn diese aufgrund von Kontraindikationen nicht durchgeführt werden kann.
Identifiants
pubmed: 33459811
doi: 10.1007/s00117-021-00805-7
pii: 10.1007/s00117-021-00805-7
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
177-182Références
Bakker MF, De Lange SV, Pijnappel RM et al (2019) Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 381:2091–2102
doi: 10.1056/NEJMoa1903986
Diekmann F, Diekmann S, Jeunehomme F et al (2005) Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement. Invest Radiol 40:397–404
doi: 10.1097/01.rli.0000167421.83203.4e
Diekmann F, Diekmann S, Taupitz M et al (2003) Use of iodine-based contrast media in digital full-field mammography—initial experience. Rofo 175:342–345
doi: 10.1055/s-2003-37828
Diekmann F, Freyer M, Diekmann S et al (2011) Evaluation of contrast-enhanced digital mammography. Eur J Radiol 78:112–121
doi: 10.1016/j.ejrad.2009.10.002
Dromain C, Balleyguier C, Muller S et al (2006) Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography. AJR Am J Roentgenol 187:W528–537
doi: 10.2214/AJR.05.1944
Dromain C, Thibault F, Diekmann F et al (2012) Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study. Breast Cancer Res 14:R94
doi: 10.1186/bcr3210
Dromain C, Thibault F, Muller S et al (2011) Dual-energy contrast-enhanced digital mammography: initial clinical results. Eur Radiol 21:565–574
doi: 10.1007/s00330-010-1944-y
Eskin BA, Parker JA, Bassett JG et al (1974) Human breast uptake of radioactive iodine. Obstet Gynecol 44:398–402
pubmed: 4852305
Esserman L, Cowley H, Eberle C et al (2002) Improving the accuracy of mammography: volume and outcome relationships. J Natl Cancer Inst 94:369–375
doi: 10.1093/jnci/94.5.369
Pisano ED, Hendrick RE, Yaffe MJ, Baum JK, Acharyya S, Cormack JB, Hanna LA, Conant EF, Fajardo LL, Bassett LW, D’Orsi CJ, Jong RA, Rebner M, Tosteson AN, Gatsonis CA, DMIST Investigators Group (2008) Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 246(2):376–383. https://doi.org/10.1148/radiol.2461070200
Fallenberg EM, Dromain C, Diekmann F et al (2014) Contrast-enhanced spectral mammography versus MRI: initial results in the detection of breast cancer and assessment of tumour size. Eur Radiol 24:256–264
doi: 10.1007/s00330-013-3007-7
Fallenberg EM, Dromain C, Diekmann F et al (2014) Contrast-enhanced spectral mammography: does mammography provide additional clinical benefits or can some radiation exposure be avoided? Breast Cancer Res Treat 146:371–381
doi: 10.1007/s10549-014-3023-6
Fallenberg EM, Schmitzberger FF, Amer H et al (2017) Contrast-enhanced spectral mammography vs. mammography and MRI—clinical performance in a multi-reader evaluation. Eur Radiol 27:2752–2764
doi: 10.1007/s00330-016-4650-6
Ferno M (1998) Prognostic factors in breast cancer: a brief review. Anticancer Res 18:2167–2171
pubmed: 9703779
Froeling V, Diekmann F, Renz DM et al (2013) Correlation of contrast agent kinetics between iodinated contrast-enhanced spectral tomosynthesis and gadolinium-enhanced MRI of breast lesions. Eur Radiol 23:1528–1536
doi: 10.1007/s00330-012-2742-5
Jochelson MS, Dershaw DD, Sung JS et al (2013) Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 266:743–751
doi: 10.1148/radiol.12121084
Jong RA, Yaffe MJ, Skarpathiotakis M et al (2003) Contrast-enhanced digital mammography: initial clinical experience. Radiology 228:842–850
doi: 10.1148/radiol.2283020961
Kalager M, Haldorsen T, Bretthauer M et al (2009) Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res 11:R44
doi: 10.1186/bcr2331
Lalji UC, Houben IP, Prevos R et al (2016) Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study. Eur Radiol 26:4371–4379
doi: 10.1007/s00330-016-4336-0
Lobbes MB, Lalji U, Houwers J et al (2014) Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme. Eur Radiol 24:1668–1676
pubmed: 24696228
Luczynska E, Heinze-Paluchowska S, Dyczek S et al (2014) Contrast-enhanced spectral mammography: comparison with conventional mammography and histopathology in 152 women. Korean J Radiol 15:689–696
doi: 10.3348/kjr.2014.15.6.689
Mokhtar O, Mahmoud S (2014) Can contrast enhanced mammography solve the problem of dense breast lesions? Egypt J Radiol Nucl Med 45:1043–1052
doi: 10.1016/j.ejrnm.2014.04.007
Perry N, Broeders M, De Wolf C et al (2008) European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary document. Ann Oncol 19:614–622
doi: 10.1093/annonc/mdm481
Saadatmand S, Obdeijn IM, Rutgers EJ et al (2015) Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). International journal of cancer. J Int Cancer 137:1729–1738
doi: 10.1002/ijc.29534
Tabar L, Vitak B, Chen TH et al (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260:658–663
doi: 10.1148/radiol.11110469
Tennant SL, James JJ, Cornford EJ et al (2016) Contrast-enhanced spectral mammography improves diagnostic accuracy in the symptomatic setting. Clin Radiol 71:1148–1155
doi: 10.1016/j.crad.2016.05.009
Wanders JOP, Holland K, Karssemeijer N et al (2017) The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study. Breast Cancer Res 19:67
doi: 10.1186/s13058-017-0859-9
Weigel S, Heindel W, Heidrich J et al (2017) Digital mammography screening: sensitivity of the programme dependent on breast density. Eur Radiol 27:2744–2751
doi: 10.1007/s00330-016-4636-4
Wockel A, Festl J, Stuber T et al (2018) Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-level, AWMF registry number 032/045OL, december 2017)—part 1 with recommendations for the screening, diagnosis and therapy of breast cancer. Geburtshilfe Frauenheilkd 78:927–948
doi: 10.1055/a-0646-4522
Xing D, Lv Y, Sun B et al (2019) Diagnostic value of contrast-enhanced spectral mammography in comparison to magnetic resonance imaging in breast lesions. J Comput Assist Tomogr 43:245–251
doi: 10.1097/RCT.0000000000000832